https://www.taxtmi.com/caselaws?id=165865 A medicine manufactured in accordance with the British Pharmacopoeia does not lose its pharmacopoeial character merely because accompanying literature refers to later research or additional therapeutic uses. The essential test is whether the product itself was prepared according to the applicable pharmacopoeia; additional descriptive material does not, by itself, alter the product's legal classification. On that basis, the medicine could not be treated as a patent and proprietary medicine, and its classification as such was not sustainable. en-us Sat, 27 Feb 1982 00:00:00 +0530 Thu, 14 Aug 2014 11:01:35 +0530 TaxTMI RSS Generator https://www.taxtmi.com/caselaws?id=165865 A medicine manufactured in accordance with the British Pharmacopoeia does not lose its pharmacopoeial character merely because accompanying literature refers to later research or additional therapeutic uses. The essential test is whether the product itself was prepared according to the applicable pharmacopoeia; additional descriptive material does not, by itself, alter the product's legal classification. On that basis, the medicine could not be treated as a patent and proprietary medicine, and its classification as such was not sustainable. Case-Laws Central Excise Sat, 27 Feb 1982 00:00:00 +0530 https://www.taxtmi.com/caselaws?id=165865